HeartBeam Announces FDA Submission Of HeartBeam AIMI Product
Submission Seeks Approval for the Company's Proprietary ECG Technology to Aid in Diagnosis of Heart Attack in $500 million Total Addressable Market
18+ million People in the US have Coronary Artery DiseaseSubmission Seeks Approval for the Company's Proprietary ECG Technology to Aid in Diagnosis of Heart Attack in $500 million Total Addressable Market